19.8 C
New York
Friday, July 4, 2025

Tag: license

Everest Medicines Showcases Breakthroughs in Proprietary AI-Powered mRNA Platform at 2025 R&D Day Held in Shanghai

SHANGHAI, July 4, 2025 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative...

Miss Universe Guyana Appoints Ivonn Novikova as New Assistant Director

– Honouring the Legacy of Toni Burnett with Leadership and Vision –
– Honouring the Legacy of Toni Burnett with Leadership and Vision –

FinSei Ltd Partners with FinHub.cloud to Accelerate Next-Generation Payment Solutions Across the UK and Europe

LONDON, July 4, 2025 /PRNewswire/ -- FinSei (previously AltPay.uk), an innovative fintech company specializing in secure, seamless payment services, has announced a strategic partnership with...

FinSei Ltd Partners with FinHub.cloud to Accelerate Next-Generation Payment Solutions Across the UK and Europe

LONDON, July 4, 2025 /PRNewswire/ -- FinSei (previously AltPay.uk), an innovative fintech company specializing in secure, seamless payment services, has announced a strategic partnership with...

Snow Caps THCA Flower – Extra Frosty Exotic Cannabis Strains Now Available for Sale

Las Vegas, NV, July 03, 2025 (GLOBE NEWSWIRE) -- Area 52, a vanguard in cannabinoid science and botanical engineering, today announced the debut of its 2025 THCA Snow Caps collection, a groundbreaking line of premium hemp flower completely enveloped in pure THCA diamonds. Engineered to “Alienize Your Mind,” these crystalline-coated buds represent a new frontier in potency and sensory experience for the discerning cannabis connoisseur.

Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China

Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater ChinaBrii Biosciences retains ex-Greater China rights to address the global antimicrobial...

Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China

Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater ChinaBrii Biosciences retains ex-Greater China rights to address the global antimicrobial...

XL Ventures Secures In-Principle Approval for Capital Markets Services License

SINGAPORE, July 4, 2025 /PRNewswire/ -- XL Ventures Pte Ltd, a Singapore-headquartered climate tech focused company, has received In-Principle Approval from the Monetary Authority...

BLUE & CO., LLC PROVIDES NOTICE OF DATA EVENT

CARMEL, Ind., July 3, 2025 /PRNewswire/ -- Blue & Co., LLC ("Blue") is a financial consultant for companies and is providing notice of an...

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on July 1, 2025 (the “Grant Date”), ORIC granted a total of 9,000 non-qualified stock options and 1,600 restricted stock units to one new non-executive employee who began their employment with ORIC in June 2025.

Tips for Avoiding DUI Charges on the 4th of July, According to a Defense Attorney | DUI Attorney, Wichita, KS

WICHITA, Kan., July 3, 2025 /PRNewswire/ -- The 4th of July is one of the most anticipated summer holidays. Think cookouts, lake days, fireworks,...

Monte Rosa Announces Publication in Science of Key Insights that Enable Next Generation Molecular Glue Degrader Medicines

Monte Rosa Announces Publication in Science of Key Insights that Enable Next Generation Molecular Glue Degrader Medicines

REE Automotive Receives Nasdaq Minimum Bid Price Notification

TEL AVIV, Israel, July 03, 2025 (GLOBE NEWSWIRE) -- REE Automotive Ltd. (“REE” or the “Company”) (Nasdaq: REE), an automotive technology company that develops software-defined vehicle (SDV) technology solutions, today reported that the Company received a letter (the “Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is currently not in compliance with Nasdaq Rule 5450(a)(1). In particular, the Letter stated that the Company’s closing bid price for its Class A ordinary shares (the “Ordinary Shares”) has been below $1.00 per share for the last 30 consecutive business days beginning on May 15, 2025 through June 27, 2025.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsLicense